Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...